These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18460518)

  • 1. Safety of long-acting beta-agonists in stable COPD: a systematic review.
    Rodrigo GJ; Nannini LJ; Rodríguez-Roisin R
    Chest; 2008 May; 133(5):1079-87. PubMed ID: 18460518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.
    Rodrigo GJ; Castro-Rodriguez JA; Plaza V
    Chest; 2009 Oct; 136(4):1029-1038. PubMed ID: 19633090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis.
    Rodrigo GJ; Nannini LJ
    Pulm Pharmacol Ther; 2007; 20(5):495-502. PubMed ID: 16621638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis.
    Xia N; Wang H; Nie X
    PLoS One; 2015; 10(9):e0137904. PubMed ID: 26378450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis.
    Oba Y; Chandran AV; Devasahayam JV
    COPD; 2016 Dec; 13(6):677-685. PubMed ID: 27148815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary management of chronic obstructive pulmonary disease: scientific review.
    Sin DD; McAlister FA; Man SF; Anthonisen NR
    JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
    Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
    Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
    Salpeter SR; Buckley NS; Salpeter EE
    J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
    Cazzola M; Dahl R
    Chest; 2004 Jul; 126(1):220-37. PubMed ID: 15249466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.